by John Conrad | Nov 20, 2023 | Policy News
iBIO, a life sciences industry association representing over 91,000 jobs in Illinois, joined over 100 stakeholders last week in urging Congress to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA). PAHPA expired on September 30, 2023, requiring...
by John Conrad | Nov 9, 2023 | Policy News
As startup funding is increasingly harder for Illinois startup companies to raise, it is more critical than ever that we support American innovation and job creation. However, a harmful change in the tax code threatens to stifle these efforts, especially for small...
by John Conrad | Oct 24, 2023 | iBIO News, Policy News
Key Points • iBIO is advocating for HR1651, the Ensuring Patient Access to Critical Breakthrough Products Act, to provide seniors with quicker access to life-saving medical technologies. • This bipartisan legislation seeks to create a 4-year automatic coverage period...
by John Conrad | Oct 2, 2023 | iBIO News, Policy News
Representatives John Joyce, M.D. (R-PA) and Wiley Nickel (D-NC) have recently introduced the Optimizing Research Progress Hope And New Cures (ORPHAN Cures Act). This legislation is a significant step in addressing the negative impact of the Inflation Reduction Act...
by John Conrad | Aug 30, 2023 | iBIO News, Policy News
iBIO has consistently advocated for a fast and efficient approach to Medicare coverage for groundbreaking medical devices and diagnostics that enhance patient outcomes in cases of severe or life-threatening illnesses. We commend CMS for revisiting this vital matter....
by John Conrad | Jun 5, 2023 | Policy News
New research released by Vital Transformation (VT) shows that the Inflation Reduction Act (IRA) will stifle the ability of companies to continue research and development across a broad range of therapeutic areas. The effects of the IRA will have a far more serious...
